Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART

Front Immunol. 2024 Feb 20:15:1334236. doi: 10.3389/fimmu.2024.1334236. eCollection 2024.

Abstract

Introduction: Initiation of antiretroviral treatment (ART) in patients early after HIV-infection and long-term suppression leads to low or undetectable levels of HIV RNA and cell-associated (CA) HIV DNA and RNA. Both CA-DNA and CA-RNA, overestimate the size of the HIV reservoir but CA-RNA as well as p24/cell-free viral RNA can be indicators of residual viral replication. This study describes HIV RNA amounts and levels of cytokines/soluble markers in 40 well-suppressed adolescents who initiated ART early in life and investigated which viral markers may be informative as endpoints in cure clinical trials within this population.

Methods: Forty adolescents perinatally infected with HIV on suppressive ART for >5 years were enrolled in the CARMA study. HIV DNA and total or unspliced CA-RNA in PBMCs were analyzed by qPCR/RT-qPCR and dPCR/RT-dPCR. Cell-free HIV was determined using an ultrasensitive viral load (US-VL) assay. Plasma markers and p24 were analyzed by digital ELISA and correlations between total and unspliced HIV RNA and clinical markers, including age at ART, Western Blot score, levels of cytokines/inflammation markers or HIV CA-DNA, were tested.

Results: CA-RNA was detected in two thirds of the participants and was comparable in RT-qPCR and RT-dPCR. Adolescents with undetectable CA-RNA showed significantly lower HIV DNA compared to individuals with detectable CA-RNA. Undetectable unspliced CA-RNA was positively associated with age at ART initiation and Western Blot score. We found that a higher concentration of TNF-α was predictive of higher CA-DNA and CA-RNA. Other clinical characteristics like US-VL, time to suppression, or percent CD4+ T-lymphocytes were not predictive of the CA-RNA in this cross-sectional study.

Conclusions: Low CA-DNA after long-term suppressive ART is associated with lower CA-RNA, in concordance with other reports. Patients with low CA-RNA levels in combination with low CA-DNA and low Western Blot scores should be further investigated to characterize candidates for treatment interruption trials. Unspliced CA-RNA warrants further investigation as a marker that can be prioritized in paediatric clinical trials where the sample volume can be a significant limitation.

Keywords: HIV-1; adolescents; cell-associated DNA; cell-associated RNA; cytokines; early treated; suppressed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anti-Retroviral Agents / therapeutic use
  • Cell-Free Nucleic Acids*
  • Child
  • Cross-Sectional Studies
  • Cytokines
  • DNA
  • HIV Infections* / drug therapy
  • Humans
  • RNA

Substances

  • RNA
  • Anti-Retroviral Agents
  • Cell-Free Nucleic Acids
  • Cytokines
  • DNA

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The EPIICAL project is funded through an independent grant by ViiV Healthcare UK. This work is part of the EPIICAL project (http://www.epiical.org), supported by the PENTA-ID foundation (http://penta-id.org). NML was funded by the UK government Department for Science, Innovation and Technology (DSIT). Some of the results have previously been presented at The HIV Cure Symposium, Ghent, BE, 2019 and Virtual CROI Boston, USA, 2020.